Nemaura Medical Inc. financial data

Symbol
NMRD on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
57 West 57 Th Street, Manhattan, New York
Fiscal year end
March 31

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 37.9 % -56.6%
Quick Ratio 12.1 % +17.8%
Debt-to-equity -162 % +61.6%
Return On Assets -115 % -55.2%
Operating Margin -312K % -21647%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.9M shares
Common Stock, Shares, Outstanding 28.9M shares +19.9%
Entity Public Float 25.2M USD
Common Stock, Value, Issued 28.9K USD +19.9%
Weighted Average Number of Shares Outstanding, Basic 28.9M shares +19.9%
Weighted Average Number of Shares Outstanding, Diluted 28.9M shares +19.9%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3.02K USD -99.5%
Cost of Revenue 0 USD -100%
Research and Development Expense 1.89M USD +22%
General and Administrative Expense 6.05M USD +2.76%
Operating Income (Loss) -9.34M USD -14.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.1M USD +0.66%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -10.7M USD +18.6%
Earnings Per Share, Basic -0.39 USD/shares 0%
Earnings Per Share, Diluted -0.39 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 137K USD -98.1%
Inventory, Net 3.67M USD +56.1%
Assets, Current 4.37M USD -60%
Property, Plant and Equipment, Net 559K USD -3.99%
Intangible Assets, Net (Excluding Goodwill) 384K USD -74.1%
Other Assets, Noncurrent 2.03M USD +0.37%
Assets 5.17M USD -60.1%
Accounts Payable, Current 352K USD +106%
Liabilities, Current 23M USD +73.9%
Liabilities 23M USD +0.77%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1M USD -1.72%
Retained Earnings (Accumulated Deficit) -57.8M USD -22.6%
Stockholders' Equity Attributable to Parent -17.8M USD -80.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -3.87M USD -149%
Liabilities and Equity 5.17M USD -60.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.52M USD -5.75%
Net Cash Provided by (Used in) Financing Activities -3.6M USD -4746%
Net Cash Provided by (Used in) Investing Activities -29.2K USD +86.6%
Common Stock, Shares Authorized 42M shares 0%
Common Stock, Shares, Issued 28.9M shares +19.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 137K USD -98.1%
Deferred Tax Assets, Valuation Allowance 9.66M USD +44.8%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.22 pure +4.76%
Depreciation 156K USD +13%
Payments to Acquire Property, Plant, and Equipment 29.2K USD +14.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -7M USD +60.5%
Property, Plant and Equipment, Gross 1.11M USD +38.1%
Deferred Tax Assets, Operating Loss Carryforwards 9.26M USD +38.8%
Current Income Tax Expense (Benefit) 0 USD -100%
Amortization of Intangible Assets 193K USD +110%
Depreciation, Depletion and Amortization 98.1K USD -0.72%
Deferred Tax Assets, Net of Valuation Allowance 0 USD